Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15782419rdf:typepubmed:Citationlld:pubmed
pubmed-article:15782419lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:15782419lifeskim:mentionsumls-concept:C1399358lld:lifeskim
pubmed-article:15782419lifeskim:mentionsumls-concept:C1970038lld:lifeskim
pubmed-article:15782419lifeskim:mentionsumls-concept:C0205234lld:lifeskim
pubmed-article:15782419pubmed:issue6lld:pubmed
pubmed-article:15782419pubmed:dateCreated2005-6-6lld:pubmed
pubmed-article:15782419pubmed:abstractTextWe present a patient with tremor-dominant hemiparkinsonism after a focal lesion to the substantia nigra. An excellent response to levodopa was complicated by rapid development of motor fluctuations and disabling dyskinesias. Stereotactic thalamotomy resulted in a persistent extinction of parkinsonism and of dyskinesias along with stopping dopaminergic treatment.lld:pubmed
pubmed-article:15782419pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15782419pubmed:languageenglld:pubmed
pubmed-article:15782419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15782419pubmed:citationSubsetIMlld:pubmed
pubmed-article:15782419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15782419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15782419pubmed:statusMEDLINElld:pubmed
pubmed-article:15782419pubmed:monthJunlld:pubmed
pubmed-article:15782419pubmed:issn0885-3185lld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:VymazalJosefJlld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:VladykaViliba...lld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:JechRobertRlld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:SEAYH DHDlld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:R?zickaEvzenElld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:UrgosíkDusanDlld:pubmed
pubmed-article:15782419pubmed:authorpubmed-author:MecírPetrPlld:pubmed
pubmed-article:15782419pubmed:copyrightInfo(c) 2005 Movement Disorder Society.lld:pubmed
pubmed-article:15782419pubmed:issnTypePrintlld:pubmed
pubmed-article:15782419pubmed:volume20lld:pubmed
pubmed-article:15782419pubmed:ownerNLMlld:pubmed
pubmed-article:15782419pubmed:authorsCompleteYlld:pubmed
pubmed-article:15782419pubmed:pagination759-62lld:pubmed
pubmed-article:15782419pubmed:dateRevised2007-2-20lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:meshHeadingpubmed-meshheading:15782419...lld:pubmed
pubmed-article:15782419pubmed:year2005lld:pubmed
pubmed-article:15782419pubmed:articleTitleHemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.lld:pubmed
pubmed-article:15782419pubmed:affiliationMovement Disorders Center, 1st Medical Faculty, Charles University, Katerinská 30, CZ-120 100 Prague, Czech Republic. eruzi@lf1.cuni.czlld:pubmed
pubmed-article:15782419pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15782419pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15782419lld:pubmed